These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

372 related items for PubMed ID: 21451433

  • 1. Induction of podocyte-derived VEGF ameliorates podocyte injury and subsequent abnormal glomerular development caused by puromycin aminonucleoside.
    Ma J, Matsusaka T, Yang HC, Zhong J, Takagi N, Fogo AB, Kon V, Ichikawa I.
    Pediatr Res; 2011 Jul; 70(1):83-9. PubMed ID: 21451433
    [Abstract] [Full Text] [Related]

  • 2. GIV/girdin links vascular endothelial growth factor signaling to Akt survival signaling in podocytes independent of nephrin.
    Wang H, Misaki T, Taupin V, Eguchi A, Ghosh P, Farquhar MG.
    J Am Soc Nephrol; 2015 Feb; 26(2):314-27. PubMed ID: 25012178
    [Abstract] [Full Text] [Related]

  • 3. Adrenomedullin ameliorates podocyte injury induced by puromycin aminonucleoside in vitro and in vivo through modulation of Rho GTPases.
    Dong N, Meng L, Xue R, Yu M, Zhao Z, Liu X.
    Int Urol Nephrol; 2017 Aug; 49(8):1489-1506. PubMed ID: 28528353
    [Abstract] [Full Text] [Related]

  • 4. Tolvaptan, a selective oral vasopressin V2 receptor antagonist, ameliorates podocyte injury in puromycin aminonucleoside nephrotic rats.
    Okada T, Sakaguchi T, Hatamura I, Saji F, Negi S, Otani H, Muragaki Y, Kawachi H, Shigematsu T.
    Clin Exp Nephrol; 2009 Oct; 13(5):438-446. PubMed ID: 19452240
    [Abstract] [Full Text] [Related]

  • 5. Acute podocyte vascular endothelial growth factor (VEGF-A) knockdown disrupts alphaVbeta3 integrin signaling in the glomerulus.
    Veron D, Villegas G, Aggarwal PK, Bertuccio C, Jimenez J, Velazquez H, Reidy K, Abrahamson DR, Moeckel G, Kashgarian M, Tufro A.
    PLoS One; 2012 Oct; 7(7):e40589. PubMed ID: 22808199
    [Abstract] [Full Text] [Related]

  • 6. Triptolide protects podocytes from puromycin aminonucleoside induced injury in vivo and in vitro.
    Zheng CX, Chen ZH, Zeng CH, Qin WS, Li LS, Liu ZH.
    Kidney Int; 2008 Sep; 74(5):596-612. PubMed ID: 18509322
    [Abstract] [Full Text] [Related]

  • 7. Nck proteins maintain the adult glomerular filtration barrier.
    Jones N, New LA, Fortino MA, Eremina V, Ruston J, Blasutig IM, Aoudjit L, Zou Y, Liu X, Yu GL, Takano T, Quaggin SE, Pawson T.
    J Am Soc Nephrol; 2009 Jul; 20(7):1533-43. PubMed ID: 19443634
    [Abstract] [Full Text] [Related]

  • 8. Preservations of nephrin and synaptopodin by recombinant hepatocyte growth factor in podocytes for the attenuations of foot process injury and albuminuria in nephritic mice.
    Kato T, Mizuno S, Nakamura T.
    Nephrology (Carlton); 2011 Mar; 16(3):310-8. PubMed ID: 21342325
    [Abstract] [Full Text] [Related]

  • 9. Hirudin attenuates puromycin aminonucleoside-induced glomerular podocyte injury by inhibiting MAPK-mediated endoplasmic reticulum stress.
    Long C, Lin Q, Mo J, Xiao Y, Xie Y.
    Drug Dev Res; 2022 Jun; 83(4):1047-1056. PubMed ID: 35277865
    [Abstract] [Full Text] [Related]

  • 10. Forced expression of vascular endothelial growth factor-A in podocytes decreases mesangial cell numbers and attenuates endothelial cell differentiation in the mouse glomerulus.
    Suyama M, Miyazaki Y, Matsusaka T, Sugano N, Ueda H, Kawamura T, Ogura M, Yokoo T.
    Clin Exp Nephrol; 2018 Apr; 22(2):266-274. PubMed ID: 28776225
    [Abstract] [Full Text] [Related]

  • 11. 1,25-Dihydroxyvitamin D(3) prevents puromycin aminonucleoside-induced apoptosis of glomerular podocytes by activating the phosphatidylinositol 3-kinase/Akt-signaling pathway.
    Xiao H, Shi W, Liu S, Wang W, Zhang B, Zhang Y, Xu L, Liang X, Liang Y.
    Am J Nephrol; 2009 Apr; 30(1):34-43. PubMed ID: 19202327
    [Abstract] [Full Text] [Related]

  • 12. Connective tissue growth factor modulates podocyte actin cytoskeleton and extracellular matrix synthesis and is induced in podocytes upon injury.
    Fuchshofer R, Ullmann S, Zeilbeck LF, Baumann M, Junglas B, Tamm ER.
    Histochem Cell Biol; 2011 Sep; 136(3):301-19. PubMed ID: 21814837
    [Abstract] [Full Text] [Related]

  • 13. Quantitative analysis of markers of podocyte injury in the rat puromycin aminonucleoside nephropathy model.
    Kakimoto T, Okada K, Fujitaka K, Nishio M, Kato T, Fukunari A, Utsumi H.
    Exp Toxicol Pathol; 2015 Feb; 67(2):171-7. PubMed ID: 25481214
    [Abstract] [Full Text] [Related]

  • 14. Mesenchymal Stromal Cells Induce Podocyte Protection in the Puromycin Injury Model.
    Ornellas FM, Ramalho RJ, Fanelli C, Garnica MR, Malheiros DMAC, Martini SV, Morales MM, Noronha IL.
    Sci Rep; 2019 Dec 20; 9(1):19604. PubMed ID: 31862892
    [Abstract] [Full Text] [Related]

  • 15. Close relations between podocyte injuries and membranous proliferative glomerulonephritis in autoimmune murine models.
    Kimura J, Ichii O, Otsuka S, Sasaki H, Hashimoto Y, Kon Y.
    Am J Nephrol; 2013 Dec 20; 38(1):27-38. PubMed ID: 23817053
    [Abstract] [Full Text] [Related]

  • 16. Synaptic vesicle protein 2B is expressed in podocyte, and its expression is altered in proteinuric glomeruli.
    Miyauchi N, Saito A, Karasawa T, Harita Y, Suzuki K, Koike H, Han GD, Shimizu F, Kawachi H.
    J Am Soc Nephrol; 2006 Oct 20; 17(10):2748-59. PubMed ID: 16943307
    [Abstract] [Full Text] [Related]

  • 17. IL-1 receptor signaling in podocytes limits susceptibility to glomerular damage.
    Ren J, Lu X, Hall G, Privratsky JR, Robson MJ, Blakely RD, Crowley SD.
    Am J Physiol Renal Physiol; 2022 Feb 01; 322(2):F164-F174. PubMed ID: 34894725
    [Abstract] [Full Text] [Related]

  • 18. Calcineurin inhibitors cyclosporin A and tacrolimus protect against podocyte injury induced by puromycin aminonucleoside in rodent models.
    Shen X, Jiang H, Ying M, Xie Z, Li X, Wang H, Zhao J, Lin C, Wang Y, Feng S, Shen J, Weng C, Lin W, Wang H, Zhou Q, Bi Y, Li M, Wang L, Zhu T, Huang X, Lan HY, Zhou J, Chen J.
    Sci Rep; 2016 Sep 01; 6():32087. PubMed ID: 27580845
    [Abstract] [Full Text] [Related]

  • 19. Receptor activator of NF-kappaB and podocytes: towards a function of a novel receptor-ligand pair in the survival response of podocyte injury.
    Liu S, Shi W, Xiao H, Liang X, Deng C, Ye Z, Mei P, Wang S, Liu X, Shan Z, Liang Y, Zhang B, Wang W, Liu Y, Xu L, Xia Y, Ma J, Li Z.
    PLoS One; 2012 Sep 01; 7(7):e41331. PubMed ID: 22848465
    [Abstract] [Full Text] [Related]

  • 20. Partial podocyte replenishment in experimental FSGS derives from nonpodocyte sources.
    Kaverina NV, Eng DG, Schneider RR, Pippin JW, Shankland SJ.
    Am J Physiol Renal Physiol; 2016 Jun 01; 310(11):F1397-413. PubMed ID: 27076646
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 19.